Viral Clearance: Removal of Viral Contamination in Biopharmaceutical Manufacturing

27:24
Assuring Viral Safety of the Biopharmaceutical Process

25:38
Qualification of Single Use Materials for Biopharmaceutical Manufacturing

1:20:52
ICH Q5A updates and its Impact on BioProcessing

27:14
Viral Clearance: A WuXi Advanced Therapies Perspective

53:05
USP 665 and 1665 Extractables for Components in Pharmaceutical and Biopharmaceutical Manufacturing

20:19
15-minute Webcast: Assessing Viral Clearance in Early Phase Process Development

33:14
Considerations for Validation of Filters used in (Bio)Pharmaceutical Manufacturing

47:41